{"doi":"10.1056/jc200410080000004","title":"Unknown","abstract":null,"journal":null,"year":null,"id":631740,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Preventing Myocardial Injury in Doxorubicin-Treated Children","abstract":"Doxorubicin, an effective anthracycline therapy for children with acute lymphoblastic leukemia (ALL), can cause myocardial injury, possibly when anthracycline-iron complexes generate free radicals. Dexrazoxane, a free-radical scavenger that effectively protects adults from anthracycline cardiotoxicity, was evaluated in a partially industry-supported trial in children being treated for high-risk, newly …","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19767382","pmcid":null,"openalex_id":"https://openalex.org/W2761538572","authors":[],"funders":[],"total_grants":0,"fwci":0.0,"citation_percentile":0.39235885,"influential_citations":0,"citation_trend":[],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://www.jwatch.org/jc200410080000004/2004/10/08/preventing-myocardial-injury-doxorubicin-treated","host_type":"journal"}],"fields_of_study":["Chemotherapy-induced cardiotoxicity and mitigation","Childhood Cancer Survivors' Quality of Life","Acute Lymphoblastic Leukemia research"],"mesh_terms":[],"keywords":["Dexrazoxane","Anthracycline","Doxorubicin","Medicine","Cardiotoxicity","Free radical scavenger","Scavenger","Internal medicine","Lymphoblastic Leukemia","Chemotherapy","Oncology","Radical","Cancer","Pharmacology","Leukemia","Breast cancer","Biochemistry","Oxidative stress"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Industry, innovation and infrastructure"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-06T00:34:21.162303Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}